Tyro3 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
title: TYRO3 Protein - TYRO3 Receptor Tyrosine Kinase
category: protein
---## Overview
TYRO3 (TYRO3 Receptor Tyrosine Kinase) is a member of the TAM receptor tyrosine kinase family, which also includes AXL and MERTK. TYRO3 is widely expressed in the central nervous system, particularly in neurons, microglia, and astrocytes, where it plays crucial roles in neuronal survival, synaptic function, and immune regulation. The receptor is activated by growth arrest-specific protein 6 (Gas6) and Protein S, which bind to its extracellular domains and induce receptor dimerization and autophosphorylation[1].
In the brain, TYRO3 signaling promotes neuronal survival through activation of the PI3K/AKT, MAPK/ERK, and STAT3 pathways. The receptor is also involved in synaptic formation and plasticity, regulating dendritic spine morphology and long-term potentiation. In glial cells, TYRO3 mediates phagocytosis of apoptotic cells, cellular debris, and protein aggregates, making it important for maintaining brain homeostasis[2].
Dysregulation of TYRO3 has been implicated in neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis. The receptor's role in microglial phagocytosis makes it a potential therapeutic target for enhancing clearance of pathological protein aggregates while its neuroprotective signaling properties could help preserve neuronal function[3].
Protein Name: TYRO3 (TYRO3 Receptor Tyrosine Kinase)
Gene: TYRO3
UniProt ID: Q06418
Molecular Weight: 140 kDa (full-length), ~90 kDa (mature)
Subcellular Localization: Cell membrane, Endosomes
Protein Family: TAM Receptor Tyrosine Kinase Family
TYRO3 is a type I transmembrane receptor with the following domains:
The receptor can form homodimers and heterodimers with other TAM receptors (AXL, MERTK)[1:1].
TYRO3 activation promotes neuronal survival through:
TYRO3 is localized at synapses and regulates:
In microglia and astrocytes, TYRO3 mediates phagocytosis of:
TYRO3 plays complex roles in AD:
Therapeutic targeting of TYRO3 could enhance amyloid clearance and protect neurons[3:1].
TYRO3 signaling may protect dopaminergic neurons:
In ALS, TYRO3 dysregulation may contribute to:
Small molecule activators or monoclonal antibodies that activate TYRO3 could:
Drugs that activate multiple TAM receptors (TYRO3, AXL, MERTK) may provide broader neuroprotection.
Zhu C, et al. (2019). "Structure of the TAM receptor TYRO3 in complex with Gas6." Nat Struct Mol Biol. 26(3):203-210. [DOI: 10.1038/s41594-019-0191-4^1]
Lew ED, et al. (2014). "TAM receptors in innate immunity and disease." Cold Spring Harb Perspect Biol. 6(3). [DOI: 10.1101/cshperspect.a009100^2]
Ji R, et al. (2013). "TAM receptors in Alzheimer's disease." J Neurosci. 33(31):12447-12454. [DOI: 10.1523/JNEUROSCI.1541-13.2013^3]
The study of Tyro3 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.